Soleno Therapeutics Announces Board and Executive Changes
Ticker: SLNO · Form: 8-K · Filed: 2025-01-24T00:00:00.000Z
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Solenos board and exec comp just got a shakeup.
AI Summary
On January 21, 2025, Soleno Therapeutics, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a shift in corporate governance and potentially new incentive structures for key personnel.
Why It Matters
Changes in a company's board and executive compensation can signal strategic shifts, new leadership directions, or adjustments to align incentives with performance, impacting investor confidence and future operations.
Risk Assessment
Risk Level: medium — Changes in executive and board composition can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Soleno Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 100 Marine Pkwy, Suite 400 Redwood City, CA 94065 (address) — Principal executive offices
- January 21, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers' and 'Election of Directors', but the specific names and details of these changes are not provided in this excerpt.
What are the details of the new compensatory arrangements for officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' but does not provide specific details on the nature or terms of these arrangements in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on January 21, 2025.
What is Soleno Therapeutics, Inc.'s principal executive office address?
Soleno Therapeutics, Inc.'s principal executive office is located at 100 Marine Pkwy, Suite 400, Redwood City, CA 94065.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 77-0523891.
Filing Stats: 557 words · 2 min read · ~2 pages · Grade level 14.9 · Accepted 2025-01-24 17:01:27
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SLNO NASDAQ Indicate by
Filing Documents
- d913677d8k.htm (8-K) — 30KB
- 0001193125-25-012294.txt ( ) — 149KB
- slno-20250121.xsd (EX-101.SCH) — 3KB
- slno-20250121_lab.xml (EX-101.LAB) — 18KB
- slno-20250121_pre.xml (EX-101.PRE) — 11KB
- d913677d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLENO THERAPEUTICS, INC. Date: January 24, 2025 By: /s/ Anish Bhatnagar Anish Bhatnagar Chief Executive Officer 3